| 000 | 01050 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515155018.0 | ||
| 264 | 0 | _c20110314 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1476-5454 | ||
| 024 | 7 |
_a10.1038/eye.2008.428 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDodson, P M | |
| 245 | 0 | 0 |
_aManagement of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality? _h[electronic resource] |
| 260 |
_bEye (London, England) _cMay 2009 |
||
| 300 |
_a997-1003 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aDiabetic Retinopathy _xdiagnosis |
| 650 | 0 | 4 |
_aDyslipidemias _xcomplications |
| 650 | 0 | 4 |
_aFenofibrate _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aLipids _xblood |
| 773 | 0 |
_tEye (London, England) _gvol. 23 _gno. 5 _gp. 997-1003 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/eye.2008.428 _zAvailable from publisher's website |
| 999 |
_c18615700 _d18615700 |
||